TLR activation and ionizing radiation induce strong immune responses against multiple tumor entities.

about

Immunotherapy for lung cancer Cancer immunotherapy: how low-level ionizing radiation can play a key role.Promising Targets for Cancer Immunotherapy: TLRs, RLRs, and STING-Mediated Innate Immune Pathways Isolation of Circulating Tumor Cells in an Orthotopic Mouse Model of Colorectal Cancer.

P2860

Q26751254-D7ACC51C-D3F4-457D-9B69-3A3EAF42E5D7 Q30235014-1371AD2C-355F-48AF-AAB2-0429D4853126 Q37690959-6A2C9E3D-5B27-48D4-9E5B-5CEE9188C1A2 Q51819604-EB0CF6EA-5C81-4A59-8BE1-4201BE770813

P2860

TLR activation and ionizing radiation induce strong immune responses against multiple tumor entities.

Item

http://www.wikidata.org/entity/Q41578773

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

TLR activation and ionizing ra ...... ainst multiple tumor entities.

@en

type

Item

label

TLR activation and ionizing ra ...... ainst multiple tumor entities.

@en

prefLabel

TLR activation and ionizing ra ...... ainst multiple tumor entities.

@en

P1476

TLR activation and ionizing ra ...... ainst multiple tumor entities.

@en

P2093

Conrad Rauber

http://www.w3.org/2001/XMLSchema#string

Moritz Koch

http://www.w3.org/2001/XMLSchema#string

Peter E Huber

http://www.w3.org/2001/XMLSchema#string

Sebastian Schölch

http://www.w3.org/2001/XMLSchema#string

P2860

Taking dendritic cells into medicine

In situ photoimmunotherapy: a tumour-directed treatment for melanoma.

A novel systemically administered Toll-like receptor 7 agonist potentiates the effect of ionizing radiation in murine solid tumor models

Radiotherapy combined with TLR7/8 activation induces strong immune responses against gastrointestinal tumors.

Antiviral applications of Toll-like receptor agonists.

Abscopal but desirable: The contribution of immune responses to the efficacy of radiotherapy.

Surgical excision versus imiquimod 5% cream for nodular and superficial basal-cell carcinoma (SINS): a multicentre, non-inferiority, randomised controlled trial.

Trial Watch: Anticancer radioimmunotherapy.

Low-dose irradiation programs macrophage differentiation to an iNOS⁺/M1 phenotype that orchestrates effective T cell immunotherapy.

Systemic delivery of a TLR7 agonist in combination with radiation primes durable antitumor immune responses in mouse models of lymphoma.

P304

e1042201

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/2162402X.2015.1042201

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Sebastian Schölch

Jürgen Weitz

P577

2015-05-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26451314

http://www.w3.org/2001/XMLSchema#string

P921

Toll-like receptor

P932

4589041

http://www.w3.org/2001/XMLSchema#string

TLR activation and ionizing radiation induce strong immune responses against multiple tumor entities.

about

P2860

P2860

TLR activation and ionizing radiation induce strong immune responses against multiple tumor entities.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P932